We provide venture, private equity or debt finance to regional businesses with growth ambition.
Providing the best possible support to our portfolio businesses and partners.
Striving to be the first choice for our investors, investees and colleagues.
The dedicated home of Mercia’s exclusive portfolio interviews, deep-dive blogs, insightful podcasts and educational webinars; all delivered by business leaders and industry experts.
Discover more about our Group including our approach to corporate governance and driving shareholder value
Medherant is an IP-rich University of Warwick spinout developing novel transdermal drug delivery patches.
© 2022 Mercia Asset ManagementWebsite by 438